tirzepatide from eli lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly is cracking down
Description
Give yourself some grace as you navigate your weight loss journey
Yet the question of cost is an important one
Clinical trials have shown that Semaglutide leads to substantial weight loss, with patients losing an average of 15-20% of their body weight
Good sources include eggs, Greek yoghurt, chicken, fish, tofu, lentils, beans, and cottage cheese
Theyre powerful tools to support, but not replace, healthy habits
